The impact of the fungicides mancozeb, myclobutanil, and meptyldinocap on populations of Typhlodromus pyri Scheuten was evaluated under field conditions, when applied following the good agricultural practices recommended for their use. Two complementary statistical models were used to analyze the population reduction compared to the control: a linear mixed model to estimate the mean effect of the fungicide, and a generalized linear mixed model (proportional odds mixed model) to estimate the cumulative probability for those effects being equal or less than a specific IOBC class (International Organization for Biological and Integrated Control of Noxious Animal and Plants). Findings from 27 field experiments in a range of different vine-growing regions in Europe indicated that the use of mancozeb, myclobutanil, and meptyldinocap caused minimal impact on naturally occurring populations of T. pyri. Both statistical models confirmed that although adverse effects on T. pyri can occur under certain conditions after several applications of any of the three fungicides studied, the probability of the effects occurring is low and they will not persist. These methods demonstrated how data from a series of trials could be used to evaluate the variability of the effects caused by the chemical rather than relying on the worst-case findings from a single trial.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 108 • No. 2